Practical Application of Polygenic Risk Scoring in the Human Embryo
DR. NATHAN TREFF
Nathan Treff received his PhD in Biochemistry in 2003 and performed postdoctoral fellowships in embryonic stem cell biology and reproductive genetics at the University of Wisconsin and EMD Serono. He is currently the CSO of Genomic Prediction and Reprocare Genetics Scandinavia, Board Certified in Molecular Diagnostics as a High Complexity Laboratory Director, an Associate Professor at Rutgers University, and a Senior Editor of Fertility and Sterility Science and JARG. Dr. Treff has published over 100 peer reviewed papers in reproductive genetics and has served as a member of the ASRM Research Committee for 5 years. His work has focused on development and validation of comprehensive genomic analyses in the preimplantation embryo. For his research, he received 6 prize paper awards from the ASRM, the 2013 Ira and Ester Rosenwaks Young Investigator Award, the 2013 Bonei Olam Scientific Achievement Award, a 2014 EMD Serono Grant for Fertility Innovation, and an NIH RO1 co-investigator grant. As a cofounder of Genomic Prediction, his recent published work on PGT for polygenic disease risk has been reported on by the Wall Street Journal, Netfilx, Forbes, the Economist, Nature News, MIT Technology Review, and the European Commission. Genomic Prediction recently received the New Jersey Tech Council’s Emerging Company of the Year award in 2019.